Evidence map›Paper›PMID 34458875›Full record

ArticleF&S science2021

Hyperandrogenemia alters mitochondrial structure and function in the oocytes of obese mouse with polycystic ovary syndrome.

Neil R Chappell, Beth Zhou, Pardis Hosseinzadeh, Amy Schutt, William E Gibbons, Chellakkan S Blesson

Open access · goldAbstract read
In one paragraph

Article in F&S science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Mitochondrial Dysfunction in Polycystic Ovary Syndrome.Reproductive sciences (Thousand Oaks, Calif.) · 2023
    Review
  10. Review
  11. Mitofusins: from mitochondria to fertility.Cellular and molecular life sciences : CMLS · 2022
    Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Neil R ChappellReproductive Endocrinology and Infertility Division, Department of Obstetrics and Gynecology, Baylor College of Medicine and Family Fertility Center, Texas Children's Hospital, Houston, Texas 77030, USA.
Beth ZhouReproductive Endocrinology and Infertility Division, Department of Obstetrics and Gynecology, Baylor College of Medicine and Family Fertility Center, Texas Children's Hospital, Houston, Texas 77030, USA.
Pardis HosseinzadehReproductive Endocrinology and Infertility Division, Department of Obstetrics and Gynecology, Baylor College of Medicine and Family Fertility Center, Texas Children's Hospital, Houston, Texas 77030, USA.
Amy SchuttReproductive Endocrinology and Infertility Division, Department of Obstetrics and Gynecology, Baylor College of Medicine and Family Fertility Center, Texas Children's Hospital, Houston, Texas 77030, USA.
William E GibbonsReproductive Endocrinology and Infertility Division, Department of Obstetrics and Gynecology, Baylor College of Medicine and Family Fertility Center, Texas Children's Hospital, Houston, Texas 77030, USA.
Chellakkan S BlessonReproductive Endocrinology and Infertility Division, Department of Obstetrics and Gynecology, Baylor College of Medicine and Family Fertility Center, Texas Children's Hospital, Houston, Texas 77030, USA.
Baylor College of Medicine · US

Funding

Mechanisms for Sex Differences in Metabolic ProgrammingR01DK114689 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI BLESSON, CHELLAKKAN SELVANESAN, YALLAMPALLI, CHANDRASEKHAR · 2018 to 2021
$1.6M
NIDDK NIH HHS R01 DK114689
6 · The paper itself

Abstract

capsuleHyperandrogenemia in an obese PCOS mouse model results in altered glucose/insulin metabolism and mitochondrial structure and function in the oocytes, in part explaining adverse outcomes and inheritance patterns seen in PCOS.

objectiveTo study the oocyte quality by means of mitochondrial structure and function in a well-established classic PCOS mouse model.

designAnimal study using an obese PCOS mouse model compared with control.

settingAnimal research facility in a tertiary care university hospital setting. ANIMALS: C57/B6J mice.

interventionThree week old mice had subdermal implants of DHT controlled release pellet or placebo for 90 days.

main outcome measuresThe mouse model was validated by performing glucose tolerance test, HbA1c levels, body weight and estrous cycle analyses. Oocytes were subsequently isolated and were used to investigate mitochondrial membrane potential, oxidative stress, lipid peroxidation, ATP production, mtDNA copy number, transcript abundance, histology and electron microscopy.

resultsResults showed glucose intolerance and hyperinsulinemia along with dysregulated estrus cycle. Analysis of the oocytes demonstrated impaired inner mitochondrial membrane function, increased ATP production and mtDNA copy number, altered RNA transcript abundance and aberrant ovarian histology. Electron microscopy of the oocytes showed severely impaired mitochondrial ultrastructure.

conclusionThe obese PCOS mouse model shows a decreased oocyte quality related to impaired mitochondrial function.

Indexed as

Polycystic Ovary SyndromeAdenosine TriphosphateAnimalsDNA, MitochondrialFemaleHumansMiceMice, ObeseMitochondriaObesityOocytesAdenosine TriphosphateDNA, MitochondrialAndrogenGlucose intoleranceMitochondriaOocytePCOS

Identifiers

PMID34458875
PMCPMC8392073
OpenAlexW3112582248

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.